DE69924869D1 - Medikament zur behandlung chronisch obstruktiver lungenerkrankung - Google Patents

Medikament zur behandlung chronisch obstruktiver lungenerkrankung

Info

Publication number
DE69924869D1
DE69924869D1 DE69924869T DE69924869T DE69924869D1 DE 69924869 D1 DE69924869 D1 DE 69924869D1 DE 69924869 T DE69924869 T DE 69924869T DE 69924869 T DE69924869 T DE 69924869T DE 69924869 D1 DE69924869 D1 DE 69924869D1
Authority
DE
Germany
Prior art keywords
treatment
chronic obstructive
medicament
lung disease
obstructive lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69924869T
Other languages
English (en)
Other versions
DE69924869T2 (de
Inventor
Anthony Killian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69924869D1 publication Critical patent/DE69924869D1/de
Publication of DE69924869T2 publication Critical patent/DE69924869T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
DE69924869T 1998-11-25 1999-11-24 Medikament zur behandlung chronisch obstruktiver lungenerkrankung Expired - Fee Related DE69924869T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US200037 1998-11-25
US09/200,037 US6020380A (en) 1998-11-25 1998-11-25 Method of treating chronic obstructive pulmonary disease
PCT/US1999/027897 WO2000030633A1 (en) 1998-11-25 1999-11-24 Method of treating chronic obstructive pulmonary disease

Publications (2)

Publication Number Publication Date
DE69924869D1 true DE69924869D1 (de) 2005-05-25
DE69924869T2 DE69924869T2 (de) 2006-03-09

Family

ID=22740061

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69924869T Expired - Fee Related DE69924869T2 (de) 1998-11-25 1999-11-24 Medikament zur behandlung chronisch obstruktiver lungenerkrankung

Country Status (11)

Country Link
US (1) US6020380A (de)
EP (1) EP1135117B1 (de)
JP (1) JP2002530329A (de)
AT (1) ATE293443T1 (de)
AU (1) AU1831000A (de)
CA (1) CA2352543A1 (de)
DE (1) DE69924869T2 (de)
DK (1) DK1135117T3 (de)
ES (1) ES2241350T3 (de)
PT (1) PT1135117E (de)
WO (1) WO2000030633A1 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954766A (en) * 1997-09-16 1999-09-21 Zadno-Azizi; Gholam-Reza Body fluid flow control device
US6293951B1 (en) * 1999-08-24 2001-09-25 Spiration, Inc. Lung reduction device, system, and method
US6901927B2 (en) * 2000-03-04 2005-06-07 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
US8474460B2 (en) * 2000-03-04 2013-07-02 Pulmonx Corporation Implanted bronchial isolation devices and methods
US6679264B1 (en) 2000-03-04 2004-01-20 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
WO2001089512A1 (fr) * 2000-05-26 2001-11-29 Takeda Chemical Industries, Ltd. Médicaments agissant sur les bronches
US6846319B2 (en) * 2000-12-14 2005-01-25 Core Medical, Inc. Devices for sealing openings through tissue and apparatus and methods for delivering them
US6623509B2 (en) 2000-12-14 2003-09-23 Core Medical, Inc. Apparatus and methods for sealing vascular punctures
US6896692B2 (en) 2000-12-14 2005-05-24 Ensure Medical, Inc. Plug with collet and apparatus and method for delivering such plugs
US8083768B2 (en) 2000-12-14 2011-12-27 Ensure Medical, Inc. Vascular plug having composite construction
US6890343B2 (en) * 2000-12-14 2005-05-10 Ensure Medical, Inc. Plug with detachable guidewire element and methods for use
US20020112729A1 (en) * 2001-02-21 2002-08-22 Spiration, Inc. Intra-bronchial obstructing device that controls biological interaction with the patient
US7798147B2 (en) * 2001-03-02 2010-09-21 Pulmonx Corporation Bronchial flow control devices with membrane seal
US7011094B2 (en) * 2001-03-02 2006-03-14 Emphasys Medical, Inc. Bronchial flow control devices and methods of use
US20040074491A1 (en) * 2001-03-02 2004-04-22 Michael Hendricksen Delivery methods and devices for implantable bronchial isolation devices
US6743259B2 (en) 2001-08-03 2004-06-01 Core Medical, Inc. Lung assist apparatus and methods for use
US6645205B2 (en) 2001-08-15 2003-11-11 Core Medical, Inc. Apparatus and methods for reducing lung volume
US20030050648A1 (en) * 2001-09-11 2003-03-13 Spiration, Inc. Removable lung reduction devices, systems, and methods
WO2003030975A2 (en) * 2001-10-11 2003-04-17 Emphasys Medical, Inc. Bronchial flow control devices and methods of use
US6592594B2 (en) * 2001-10-25 2003-07-15 Spiration, Inc. Bronchial obstruction device deployment system and method
US6929637B2 (en) * 2002-02-21 2005-08-16 Spiration, Inc. Device and method for intra-bronchial provision of a therapeutic agent
US20060235432A1 (en) * 2002-02-21 2006-10-19 Devore Lauri J Intra-bronchial obstructing device that controls biological interaction with the patient
US20030154988A1 (en) * 2002-02-21 2003-08-21 Spiration, Inc. Intra-bronchial device that provides a medicant intra-bronchially to the patient
WO2003075796A2 (en) * 2002-03-08 2003-09-18 Emphasys Medical, Inc. Methods and devices for inducing collapse in lung regions fed by collateral pathways
US20030216769A1 (en) 2002-05-17 2003-11-20 Dillard David H. Removable anchored lung volume reduction devices and methods
US20030181922A1 (en) 2002-03-20 2003-09-25 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US20030195385A1 (en) * 2002-04-16 2003-10-16 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US20050066974A1 (en) * 2002-05-28 2005-03-31 Antony Fields Modification of lung region flow dynamics using flow control devices implanted in bronchial wall channels
US20040059263A1 (en) * 2002-09-24 2004-03-25 Spiration, Inc. Device and method for measuring the diameter of an air passageway
US20040010209A1 (en) * 2002-07-15 2004-01-15 Spiration, Inc. Device and method for measuring the diameter of an air passageway
AU2003256798A1 (en) * 2002-07-26 2004-02-16 Emphasys Medical, Inc. Bronchial flow control devices with membrane seal
ATE444722T1 (de) * 2002-11-27 2009-10-15 Pulmonx Corp Einführbesteck für implantierbare bronchiale isolationsvorrichtungen
US7814912B2 (en) * 2002-11-27 2010-10-19 Pulmonx Corporation Delivery methods and devices for implantable bronchial isolation devices
US7100616B2 (en) * 2003-04-08 2006-09-05 Spiration, Inc. Bronchoscopic lung volume reduction method
US7200559B2 (en) * 2003-05-29 2007-04-03 Microsoft Corporation Semantic object synchronous understanding implemented with speech application language tags
US7533671B2 (en) 2003-08-08 2009-05-19 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
US7361183B2 (en) 2003-10-17 2008-04-22 Ensure Medical, Inc. Locator and delivery device and method of use
US8852229B2 (en) * 2003-10-17 2014-10-07 Cordis Corporation Locator and closure device and method of use
US20050178389A1 (en) * 2004-01-27 2005-08-18 Shaw David P. Disease indications for selective endobronchial lung region isolation
US8206684B2 (en) * 2004-02-27 2012-06-26 Pulmonx Corporation Methods and devices for blocking flow through collateral pathways in the lung
EP2368525B1 (de) * 2004-03-08 2019-09-18 Pulmonx, Inc Implantierte Bronchialisolationsvorrichtungen
US20060030863A1 (en) * 2004-07-21 2006-02-09 Fields Antony J Implanted bronchial isolation device delivery devices and methods
WO2006009209A1 (ja) * 2004-07-22 2006-01-26 Kaken Pharmaceutical Co., Ltd. 慢性炎症性肺疾患を予防もしくは治療する薬剤
US9211181B2 (en) 2004-11-19 2015-12-15 Pulmonx Corporation Implant loading device and system
US7771472B2 (en) * 2004-11-19 2010-08-10 Pulmonx Corporation Bronchial flow control devices and methods of use
US8876791B2 (en) 2005-02-25 2014-11-04 Pulmonx Corporation Collateral pathway treatment using agent entrained by aspiration flow current
US8088144B2 (en) * 2005-05-04 2012-01-03 Ensure Medical, Inc. Locator and closure device and method of use
US8926654B2 (en) 2005-05-04 2015-01-06 Cordis Corporation Locator and closure device and method of use
US7691151B2 (en) * 2006-03-31 2010-04-06 Spiration, Inc. Articulable Anchor
US7829986B2 (en) * 2006-04-01 2010-11-09 Stats Chippac Ltd. Integrated circuit package system with net spacer
WO2008027293A2 (en) * 2006-08-25 2008-03-06 Emphasys Medical, Inc. Bronchial isolation devices for placement in short lumens
WO2009007674A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast
US8043301B2 (en) * 2007-10-12 2011-10-25 Spiration, Inc. Valve loader method, system, and apparatus
CN101868199B (zh) 2007-10-12 2016-04-06 斯波瑞申有限公司 阀装载器方法、系统以及设备
US8795241B2 (en) 2011-05-13 2014-08-05 Spiration, Inc. Deployment catheter
WO2014011273A2 (en) * 2012-04-09 2014-01-16 THE REGENTS OF THE UNIVERSITY OF COLORADO a body corporate of the state of colorado Pro-inflammatory mediators in diagnosis and treatment of pulmonary disease
US20150269348A1 (en) * 2014-03-24 2015-09-24 AsthmaMD, Inc. Systems and methods for health management

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304658A (en) * 1984-08-01 1994-04-19 Takeda Chemical Industries, Ltd. Quinone derivatives, their production and use
WO1986000887A1 (en) * 1984-08-01 1986-02-13 Takeda Chemical Industries, Ltd. Quinone derivatives, process for their preparation, and medicinal composition containing the same
MX9203040A (es) * 1984-08-01 1992-07-31 Takeda Chemical Industries Ltd Derivados de quinona y composicion farmaceutica que los contiene.
US4851586A (en) * 1985-09-20 1989-07-25 The Upjohn Company 1,4-naphthalenediol and 1,4-hydroquinone derivatives
US4939169A (en) * 1985-09-20 1990-07-03 The Upjohn Company 1,4-naphthalenediol and 1,4-hydroquinone derivatives
US4808627A (en) * 1987-12-16 1989-02-28 E. R. Squibb & Sons, Inc. Method of preventing or treating toxemia in pregnancy using a thromboxane A2 receptor antagonist
US5021448A (en) * 1990-02-22 1991-06-04 Ciba-Geigy Corporation Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor inhibitor and/or thromboxane receptor antagonist
US5096916A (en) * 1990-05-07 1992-03-17 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
US5534548A (en) * 1994-05-03 1996-07-09 Tap Pharmaceuticals, Inc. Method of treating preeclampsia

Also Published As

Publication number Publication date
DK1135117T3 (da) 2005-08-15
US6020380A (en) 2000-02-01
PT1135117E (pt) 2005-08-31
CA2352543A1 (en) 2000-06-02
AU1831000A (en) 2000-06-13
JP2002530329A (ja) 2002-09-17
ES2241350T3 (es) 2005-10-16
DE69924869T2 (de) 2006-03-09
EP1135117B1 (de) 2005-04-20
EP1135117A1 (de) 2001-09-26
WO2000030633A1 (en) 2000-06-02
ATE293443T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
DE69924869D1 (de) Medikament zur behandlung chronisch obstruktiver lungenerkrankung
DE69921941D1 (de) Verfahren zur Herstellung von pharmazeutischen Wirkstoffpartikeln
DE60128258D1 (de) Indanylderivate zur Behandlung von Atemwegserkrankungen
DE69735674D1 (de) Verfahren zur hemmung der fibrose mittels eines somatostatin-agonisten
EE05215B1 (et) Meetod tskloproplkarbokslhappe estrite ja derivaatide valmistamiseks
ES2189874T3 (es) Dinucleotidos utiles para el tratamiento de enfermedades pulmonares.
KR920012040A (ko) 신규의 디히드로-이소퀴놀린 유도체
SE9504537D0 (sv) Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
WO2001019814A3 (en) Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
CA2264005A1 (en) Piperazino derivatives as neurokinin antagonists
WO2001019819A3 (en) Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
FR2864061B1 (fr) Procede de preparation d'un phosphate de lanthanides et du phosphate ainsi prepare
FR2791673B1 (fr) Procede de preparation des esters de l'acide hydroxymethylthiobutyrique
DE69901519D1 (de) Verfahren zur Herstellung von 2,2'-bis (Hydroxymethyl)alkansäure
DE60043261D1 (de) Verfahren zur herstellung von phenylessigsäure derivaten
EA200200518A1 (ru) Способ и композиция для лечения заболеваний легких
NO975921D0 (no) Fremstilling av bicykloheksanderivater
EP0388049A3 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen
EP0207497A3 (de) Chinoloncarbonsäurederivat und Verfahren zu seiner Herstellung
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk
DE60005262D1 (de) Verfahren zum Herstellen von Trifluoressigsäureester und -thioester
DE69814204D1 (de) Verfahren zur Herstellung von 2,2'-bis(Hydroxymethyl)alkanal und 2,2'-bis(Hydroxymethyl)alkansäure
AU2003257473A1 (en) Modified amino acid for the inhibition of platelet aggregation
DE60004996D1 (de) Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen
IT1273998B (it) Metodo per la produzione di sali di calcio di acidi deboli

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee